Independent of one another, therapeutic vaccines and immune checkpoint inhibition with anti-programmed cell death 1 (PD-1) antibodies have proven largely ineffective in treating recurrent ...
The alternative text for this image may have been generated using AI. Human papillomavirus (HPV) vaccines are in wide use around the world owing to the widespread implementation of immunization ...
In a recent meta-analysis, the prevalence of human papillomavirus (HPV), especially types 16 and 18, was significantly increased among patients with ovarian cancer (OC) vs controls. Over 300,000 new ...
Like any shot, the HPV vaccine can cause pain at the injection site. But the VIP report, which includes 274 studies, found no ...
November 6, 2008 — Human papillomavirus (HPV) infection has recently been established as an important risk factor for oropharyngeal cancers. Using a noninvasive oral rinse, researchers have now ...
Vaccines work well to prevent cancers caused by the human papillomavirus (HPV). So well, in fact, that it may be time to review HPV screening protocols, according to the somewhat provocative ...
Phase I study of teclistamab, a humanized B-cell maturation antigen (BCMA) x CD3 bispecific antibody, in relapsed/refractory multiple myeloma (R/R MM). This is an ASCO Meeting Abstract from the 2020 ...
HPV is the most common STI. It’s also one that can go unnoticed, as it often doesn’t show symptoms. Though the immune system often clears the virus on its own, certain strains of HPV can cause genital ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results